Kovacic-Milivojević B, LaPointe M C, Reker C E, Vedeckis W V
Biochemistry. 1985 Dec 3;24(25):7357-66. doi: 10.1021/bi00346a050.
The glucocorticoid receptor from mouse AtT-20 pituitary tumor cells exists in three forms. The largest form is an untransformed (non-DNA-binding), oligomeric species (9.1 S, 8.3 nm, Mr 319 000). Two transformed (DNA-binding) forms can be generated. One is an oligomeric protein (5.2 S, 6-8.3 nm, Mr 132 000-182 000), while the other is the monomeric, hormone-binding subunit (3.8 S, 6 nm, Mr 96 000). The composition of the oligomeric, transformed receptor and its relationship to the monomeric protein were examined. The 3.8S monomer can be isolated from DEAE-cellulose (0.12 M step elution) in a form that continues to sediment at about 3.8 S on molybdate-containing sucrose gradients and at about 4.2 S on molybdate-free gradients. Addition of a non-hormone-binding component isolated from the same DEAE-cellulose column (0.5 M KCl step) can apparently interact with the 3.8-4.2 S monomer, increasing its sedimentation coefficient to 5.2 S (on molybdate-containing gradients) or 6.6 S (on low-salt, molybdate-free gradients). This factor is a macromolecule (nondialyzable) and is heat-stable (100 degrees C, 20 min). A dose-dependent shift to the higher sedimentation coefficient is observed when increasing quantities of the 0.5 M step material are added to the receptor monomer. This activity is abolished when the 0.5 M step material is treated with ribonuclease A. Further, when RNA is purified from the 0.5 M step by phenol/chloroform extraction, its ability to increase the S value of the monomer is retained. Ribonuclease treatment of the untransformed, 9.1S, oligomeric complex does not cause a significant decrease in sedimentation rate, while the same treatment of the 5.2S, oligomeric, transformed receptor (obtained after Sephadex G-25 transformation) causes a decrease in sedimentation rate to about 3.8 S. The addition of bovine liver mRNA and rRNA does not cause a shift in sedimentation rate of the receptor monomer to a discrete, higher sedimenting receptor form. However, the addition of total rabbit liver tRNA or three distinct tRNA species causes a shift in sedimentation to a similar, but not identical, form as that with the 0.5 M step material. We propose that the 5.2S, oligomeric transformed glucocorticoid receptor is composed of one monomeric hormone-binding, protein subunit (Mr 96 000) and a low molecular weight RNA (Mr 36 000). This interaction may be important for the role of the receptor in regulating gene expression.
来自小鼠AtT - 20垂体瘤细胞的糖皮质激素受体存在三种形式。最大的形式是未转化的(非DNA结合)寡聚体(9.1 S,8.3纳米,相对分子质量319000)。可以产生两种转化的(DNA结合)形式。一种是寡聚蛋白(5.2 S,6 - 8.3纳米,相对分子质量132000 - 182000),而另一种是单体的激素结合亚基(3.8 S,6纳米,相对分子质量96000)。研究了寡聚的、转化的受体的组成及其与单体蛋白的关系。3.8S单体可以从DEAE - 纤维素(0.12 M阶跃洗脱)中分离出来,其形式在含钼酸盐的蔗糖梯度上继续以约3.8 S沉降,在无钼酸盐梯度上以约4.2 S沉降。从同一DEAE - 纤维素柱(0.5 M KCl阶跃)分离出的非激素结合成分显然可以与3.8 - 4.2 S单体相互作用,将其沉降系数提高到5.2 S(在含钼酸盐梯度上)或6.6 S(在低盐、无钼酸盐梯度上)。这个因子是一种大分子(不可透析)且热稳定(100℃,20分钟)。当向受体单体中添加越来越多的0.5 M阶跃材料时,观察到向更高沉降系数的剂量依赖性转变。当0.5 M阶跃材料用核糖核酸酶A处理时,这种活性被消除。此外,当通过苯酚/氯仿萃取从0.5 M阶跃中纯化RNA时,其增加单体S值的能力得以保留。对未转化的9.1S寡聚复合物进行核糖核酸酶处理不会导致沉降速率显著降低,而对5.2S寡聚的、转化的受体(在Sephadex G - 25转化后获得)进行相同处理会导致沉降速率降低到约3.8 S。添加牛肝mRNA和rRNA不会导致受体单体的沉降速率转变为离散的、沉降更快的受体形式。然而,添加兔肝总tRNA或三种不同的tRNA种类会导致沉降转变为与0.5 M阶跃材料相似但不完全相同的形式。我们提出5.2S寡聚转化的糖皮质激素受体由一个单体的激素结合蛋白亚基(相对分子质量96000)和一种低分子量RNA(相对分子质量36000)组成。这种相互作用可能对受体在调节基因表达中的作用很重要。